İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2024 · article

Structural and Functional Impact of Adrenoceptor Beta-1 Gene Polymorphism in Patients with Hypertrophic Cardiomyopathy and Response to Beta-Blocker Therapy

ISSN2149-2263
YÖKSİS OpenAlex Açık erişim · diamond TR Index
Yıl2024
Atıf3OpenAlex
Yüzdelik%73,9
FWCI0,841,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıThe Anatolian Journal of Cardiology
  • Katalog eşleşmesi (ISSN)Anatolian Journal of Cardiology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetically inherited cardiac disorder with diverse clinical presentations. Adrenergic activity, primarily mediated through beta-adrenoceptors, plays a central role in the clinical course of HCM. Adrenergic stimulation increases cardiac contractility and heart rate through beta-1 adrenoceptor activation. Beta-blocker drugs are recommended as the primary treatment for symptomatic HCM patients to mitigate these effects. METHODS: This prospective study aimed to investigate the impact of common ADRB-1 gene polymorphisms, specifically serine-glycine at position 49 and arginine-glycine at position 389, on the clinical and structural aspects of HCM. Additionally, the study explored the association between these genetic variations and the response to beta-blocker therapy in HCM patients. RESULTS: A cohort of 147 HCM patients was enrolled, and comprehensive assessments were performed. The findings revealed that the Ser49Gly polymorphism significantly influenced ventricular ectopic beats, with beta-blocker therapy effectively reducing them in Ser49 homozygous patients. Moreover, natriuretic peptide levels decreased, particularly in Ser49 homozygotes, indicating improved cardiac function. Left ventricular outflow obstruction, a hallmark of HCM, was also reduced following beta-blocker treatment in all patient groups. In contrast, the Arg389Gly polymorphism did not significantly impact baseline parameters or beta-blocker response. CONCLUSION: These results emphasize the role of the Ser49Gly polymorphism in the ADRB-1 gene in shaping the clinical course and response to beta-blocker therapy in HCM patients. This insight may enable a more personalized approach to managing HCM by considering genetic factors in treatment decisions. Further research with larger populations and longer follow-up periods is needed to confirm and expand upon these findings.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

3atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 2 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 Recent Developments in Adrenergic Receptor Polymorphisms in Essential HypertensionAtıf 0 · OpenAlex
  2. 2025 Recent Developments in Adrenergic Receptor Polymorphisms in Essential HypertensionAtıf 0 · OpenAlex

Yazarlar

14
  1. DAMLA RAIMOGLOU İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 1
  2. CEMİL İZGİ 2
  3. RASİM ENAR 3
  4. MEHMET HAKAN KARPUZ 4
  5. BİLGEHAN KARADAĞ 5
  6. BARIŞ İKİTİMUR İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 6
  7. Utku Raimoğlu 7
  8. ALİ UĞUR SOYSAL 8
  9. OSMAN AYKAN KARGIN 9
  10. MEHMET GÜVEN 10
  11. Namina Malikova 11
  12. ELİF ÇITAK ERDOĞAN 12
  13. ECE YURTSEVEN 13
  14. ESER DURMAZ 14